NEW YORK (GenomeWeb News) – The ALS Therapy Development Institute, a non-profit that is focused on advancing research into amyotrophic lateral sclerosis, or Lou Gehrig’s disease, said today that it is accelerating its efforts to discover biomarkers that could be used in combating the disease.

The group said it is expanding its effort to collect samples for use in the program, which seeks to identify altered expression of genes and proteins that could be potential biomarkers for diagnosing and monitoring the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.